Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. - Wikidata - awgldk - TriplyDB

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.

http://www.wikidata.org/entity/Q34455482

about

Immunosuppressive agents for treating IgA nephropathy Recent advances in the understanding and management of IgA nephropathy New developments in the genetics, pathogenesis, and therapy of IgA nephropathy The Treatment of IgA Nephropathy Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.Nationwide survey on current treatments for IgA nephropathy in Japan.Glomerular diseases: emerging tests and therapies for IgA nephropathy Treatment of IgA nephropathy: an update.Treatment of IgA nephropathy and Henoch-Schönlein nephritis.Treatment of IgA nephropathy with renal insufficiency.Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?Inflammation in IgA nephropathy.Is there a role for immunosuppression in immunoglobulin A nephropathy?Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.Successful treatment of adult IgA nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine.Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy.Steroids and azathioprine in the treatment of IgA nephropathy.IgA Nephropathy.Primary IgA nephropathy: current challenges and future prospects.Con: STOP immunosuppression in IgA nephropathy.Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.Pregnancy in a woman with recurrent immunoglobulin a nephropathy: A case report The Emerging Role of Pathogenesis of IgA Nephropathy A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study

P2860

Q24188035-1E807002-E782-47D5-9AD5-A2E1EFF4D664 Q26766126-4BE24ECE-DD65-4D79-8ECA-1111F10AE42C Q26786248-DC9B5030-5CDC-40C5-8ACE-55D05BDCD9D8 Q27005109-4D64DC2D-0EEB-4555-A5C9-FEC1C9FC43A7 Q34557198-B7797B26-CF03-421C-8318-414578292519 Q35743170-3DC59890-BD21-4A69-A7AC-F77E9BF04724 Q36077744-FAC66429-9AB4-4421-99DA-A1CA5F52D288 Q36447934-E93ABCDB-EC9F-48BA-B8FA-49EF843DC2E5 Q37115267-384730AD-A803-42EE-A0DA-A2A3BE4E01A7 Q37185408-852E65D2-1C79-40C3-8FC5-62327C362DE8 Q37467985-CFCBADE3-FDCF-410B-B08A-BCDBA2CC86F2 Q37621563-F80681A5-EA61-4973-84B1-C0EC03BE82E8 Q37939849-D6461AD6-5DD8-4F66-9FD1-93BC811FE9A9 Q38094888-03944154-DCC3-4CCA-8348-3B863FF50F69 Q38689787-A8C6D619-805B-4685-AE9B-CB4DB4F4F3FA Q38817381-86EDCFE9-2FC4-486B-A37B-AFDE17E9301F Q38860793-A2E9B285-6263-4485-B0B8-6DCDC5C4E73D Q39178756-58074872-C344-423B-B49F-00AE0D957600 Q39229309-4AA15680-2D41-4FE3-ACEB-BD9D9661B519 Q39809045-5C614482-BC7D-4C28-9AC9-3CF51CE79FC0 Q40982974-F6B67148-995F-4BBE-B7CF-C175B217C12E Q41145470-BC532CE6-8E1E-4DD7-AB20-2AB224CDEF78 Q41471646-9CF59EB5-1CFF-437F-8674-7BAD6F9A602B Q42217075-FF8E1E7A-A12F-4490-9AD3-3E21A48396D3 Q47773361-6CC0B1D0-54EA-4DEC-B633-C44178304897 Q49477908-FE960F74-F358-4286-A137-D46C2A15F461 Q50506285-DA411AA9-313F-499D-98E7-F23738C7493E Q51605419-67BA07BF-694C-46B1-B4CF-B14C974B3094 Q51834649-C33FC01A-7F7D-4694-B59A-5C1DB87D9B52 Q52309425-5919D107-1FF2-4A71-9798-5EC5A6E2EC3C Q53556768-85EE1EB3-F67F-4B20-9DF9-BF9EC0872924 Q53706807-01200FC6-B3D7-43D3-8B99-DE7CC1AA7842 Q58711011-A5009E50-1878-49B2-901A-280BCD0903AB Q58734688-1BC54F67-1A29-4ED2-91AE-99E9D34470C0 Q58747430-19B867C7-055A-4802-BC49-EEAF1C4AF2A3

P2860

Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.

http://www.wikidata.org/entity/Q34455482

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Addition of azathioprine to co ...... patients with IgA nephropathy.

@ast

Addition of azathioprine to co ...... patients with IgA nephropathy.

@en

Addition of azathioprine to co ...... patients with IgA nephropathy.

@nl

type

label

Addition of azathioprine to co ...... patients with IgA nephropathy.

@ast

Addition of azathioprine to co ...... patients with IgA nephropathy.

@en

Addition of azathioprine to co ...... patients with IgA nephropathy.

@nl

prefLabel

Addition of azathioprine to co ...... patients with IgA nephropathy.

@ast

Addition of azathioprine to co ...... patients with IgA nephropathy.

@en

Addition of azathioprine to co ...... patients with IgA nephropathy.

@nl

P1433

Q34455482-EC0E04F7-3E72-4A4C-80F5-1B102B64A4ED

P1476

Q34455482-081010CF-2A8D-4679-AC4D-77E8FBFBAE4B

P2093

Q34455482-3ABA1FB0-D281-4F40-8FC1-8E627CFC3A2B

Q34455482-3E4CD8DB-4C40-47FE-AC82-65C54921B4F7

Q34455482-405679A7-C95B-4E52-9FA7-94755E4DC2E6

Q34455482-5AC76723-9276-4A09-80C5-66DC992DD4CE

Q34455482-6A9BFD4B-CD8A-4707-B475-3D4E1FEA4D2D

Q34455482-7A654239-7221-4930-A89B-F5762A9A6C62

Q34455482-7D2E9050-4F7B-46E7-A1A2-FAB66F22F10A

Q34455482-81D4434A-7918-4B9B-9750-36BC1B5A9F0A

Q34455482-A2C696E9-DBE4-4EB3-B4FA-2FA62912CBE4

Q34455482-A8582117-AD05-4C64-9BCC-7B1A88D35ADA

P2860

Q34455482-2037E2F5-85DE-4970-B7EC-7B3429CCFCAA

Q34455482-248D94EB-6329-4CE6-9B76-1546761B71A6

Q34455482-25397FC5-3E8D-4076-B341-1A865F2FB7C2

Q34455482-2F1E7EEF-3231-4437-B8F7-F7B197570996

Q34455482-33DF7D83-CCD0-434A-8273-A4F5F2F6574B

Q34455482-3BB844BB-9987-4570-8084-7696D7F86F1C

Q34455482-589F396E-9926-4CB1-B450-A0A8B5240A44

Q34455482-5BE71202-5E5B-4A58-BDBB-6446E30010FB

Q34455482-6AC27836-FD75-40E1-BF01-F245350797A7

Q34455482-6D5B548D-2E24-4565-A005-07B4A6C4B750

P304

Q34455482-5D8BE57C-5C4A-4803-AF5F-D43EEC8416AE

P31

Q34455482-6B33C6AA-180C-49C2-86DE-C939FB1F3FFD

P356

Q34455482-56325110-2582-4B25-B70D-B7D21CF73599

P433

Q34455482-58A00684-FF62-41C6-9ADA-1BF8121E8FA1

P478

Q34455482-078A420A-A500-4B06-8760-58607F1A72DF

P577

Q34455482-D8B52420-98B9-4828-88AF-93D679B1923D

P698

Q34455482-D952F1F1-A12D-44E7-A66C-DFBB04F64BF0

P932

Q34455482-5E0DD199-6E21-44E7-9E21-810A2ABFDF4A

P356

P1433

Journal of the American Society of Nephrology

P1476

Addition of azathioprine to co ...... patients with IgA nephropathy.

@en

P2093

Aldo Deni Procaccini

http://www.w3.org/2001/XMLSchema#string

Antonello Pani

http://www.w3.org/2001/XMLSchema#string

Bruno Vogt

http://www.w3.org/2001/XMLSchema#string

Claudio Pozzi

http://www.w3.org/2001/XMLSchema#string

Francesco Locatelli

http://www.w3.org/2001/XMLSchema#string

Giambattista Fogazzi

http://www.w3.org/2001/XMLSchema#string

Landino Allegri

http://www.w3.org/2001/XMLSchema#string

Lino Cirami

http://www.w3.org/2001/XMLSchema#string

Lucia Del Vecchio

http://www.w3.org/2001/XMLSchema#string

Patrizia Scaini

http://www.w3.org/2001/XMLSchema#string

P2860

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Prediction of creatinine clearance from serum creatinine

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Predicting progression in IgA nephropathy.

Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.

An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.

Long-term study of mycophenolate mofetil treatment in IgA nephropathy.

Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.

P304

1783-1790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010010117

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20634300

http://www.w3.org/2001/XMLSchema#string

P932

3013548

http://www.w3.org/2001/XMLSchema#string